Associated Papers
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis.
Kim B et al.
Computational and Structural Biotechnology Journal, 2023
Novel Antibody for the Treatment of Transthyretin Amyloidosis.
Hosoi A et al.
The Journal of Biological Chemistry, 2016
Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
Trivella DB et al.
Journal of Structural Biology, 2010
Select a paper to view details